AntiCancerpeptides.org

Why this name

Anticancer peptides are a defined class in the oncology literature: short amino acid sequences studied for selective cytotoxicity, tumor targeting, and drug delivery. The plural phrasing reads as a field rather than a product, and .org carries the tone of laboratories, review journals, and open databases instead of commercial promise. Anyone typing the term is a researcher, a grant writer, or a graduate student trying to find the current state of the work.

It belongs with a university lab group, a peptide chemistry consortium, an open-access sequence database, or a foundation funding translational oncology. A coined acronym would spend years earning subject authority; this name arrives with the vocabulary of the discipline attached, and doubles as a durable home for a symposium or a publication series.

Well suited to

• Open-access peptide sequence and bioactivity database
• Academic lab or consortium website
• Oncology research foundation
• Annual symposium and proceedings site
• Peer-reviewed review publication

Ideal owner A research institute, peptide chemistry consortium, or oncology-focused nonprofit.